GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tien Liang BioTech Co Ltd (ROCO:4127) » Definitions » Cyclically Adjusted PS Ratio

Tien Liang BioTech Co (ROCO:4127) Cyclically Adjusted PS Ratio : 2.58 (As of Jun. 19, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Tien Liang BioTech Co Cyclically Adjusted PS Ratio?

As of today (2024-06-19), Tien Liang BioTech Co's current share price is NT$40.00. Tien Liang BioTech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was NT$15.51. Tien Liang BioTech Co's Cyclically Adjusted PS Ratio for today is 2.58.

The historical rank and industry rank for Tien Liang BioTech Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

ROCO:4127' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.51   Med: 0.81   Max: 2.92
Current: 2.63

During the past years, Tien Liang BioTech Co's highest Cyclically Adjusted PS Ratio was 2.92. The lowest was 0.51. And the median was 0.81.

ROCO:4127's Cyclically Adjusted PS Ratio is ranked worse than
60.03% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs ROCO:4127: 2.63

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tien Liang BioTech Co's adjusted revenue per share data for the three months ended in Mar. 2024 was NT$2.576. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$15.51 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tien Liang BioTech Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Tien Liang BioTech Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tien Liang BioTech Co Cyclically Adjusted PS Ratio Chart

Tien Liang BioTech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.67 0.88 0.93 0.93

Tien Liang BioTech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 0.96 0.85 0.93 1.90

Competitive Comparison of Tien Liang BioTech Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tien Liang BioTech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tien Liang BioTech Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tien Liang BioTech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tien Liang BioTech Co's Cyclically Adjusted PS Ratio falls into.



Tien Liang BioTech Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Tien Liang BioTech Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=40.00/15.51
=2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tien Liang BioTech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tien Liang BioTech Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.576/131.7762*131.7762
=2.576

Current CPI (Mar. 2024) = 131.7762.

Tien Liang BioTech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.451 100.560 5.833
201409 4.884 100.428 6.409
201412 4.595 99.070 6.112
201503 5.142 99.621 6.802
201506 4.826 100.684 6.316
201509 4.295 100.392 5.638
201512 4.119 99.792 5.439
201603 4.534 100.470 5.947
201606 4.259 101.688 5.519
201609 3.822 101.861 4.944
201612 3.920 101.863 5.071
201703 3.681 102.862 4.716
201706 2.591 103.349 3.304
201709 2.128 104.136 2.693
201712 2.871 104.011 3.637
201803 2.733 105.290 3.421
201806 3.039 106.317 3.767
201809 2.655 106.507 3.285
201812 3.214 105.998 3.996
201903 2.427 107.251 2.982
201906 2.171 108.070 2.647
201909 2.077 108.329 2.527
201912 2.858 108.420 3.474
202003 2.643 108.902 3.198
202006 2.248 108.767 2.724
202009 2.108 109.815 2.530
202012 2.407 109.897 2.886
202103 2.468 111.754 2.910
202106 2.965 114.631 3.408
202109 3.458 115.734 3.937
202112 3.572 117.630 4.002
202203 3.264 121.301 3.546
202206 2.708 125.017 2.854
202209 2.685 125.227 2.825
202212 2.923 125.222 3.076
202303 2.733 127.348 2.828
202306 2.415 128.729 2.472
202309 2.263 129.860 2.296
202312 2.548 129.419 2.594
202403 2.576 131.776 2.576

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tien Liang BioTech Co  (ROCO:4127) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Tien Liang BioTech Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Tien Liang BioTech Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tien Liang BioTech Co (ROCO:4127) Business Description

Traded in Other Exchanges
N/A
Address
Datong Road, 9F, No. 147, Sec. 1, Xizhi District, New Taipei City, TWN
Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis and hepatic diseases.

Tien Liang BioTech Co (ROCO:4127) Headlines

No Headlines